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1. Introduction 
During the recent years was possible to witness significant changes in the incidence and 
types of lung pathology seen by clinicians. It is important to mention that lung pathologies 
are some of the most common medical conditions worldwide. 
Lung cancer was a rare disease in the early 1900s, but has since become far more prevalent 
and this lung pathology remains one of the greatest medical challenges with nearly 1.5 
million cases worldwide each year and is the most common cause of cancer death in the 
world (Harewood GC et al., 2002) and (Spiro SG et al., 2010). It is typically a disease of 
elderly patients, with a peak incidence at around 70-80 years of age (Chen YM et al., 2009). 
The incidence and mortality of lung cancer have increased sharply during this century, 
making it a common cause of death and the most frequent fatal cancer in men and women 
(Beckett WS, 1993). Clearly, lung cancer is an important and widespread disease that 
constitutes a major public health problem (Witschi H, 2001). 
From all malignant tumors, except for non-melanoma skin cancer, lung cancer is the second 
most common type among men and the most frequent among women. The most concerning 
characteristics of this kind of cancer is that it has caused more deaths that the sum of the 
deaths caused by prostate, breast and rectal cancer in developed countries (Silva AC et al., 
2011). 
Smoking is estimated to be the cause of 85% of lung cancer deaths (Agarwal A et al., 2003). It 
is important to remind that the consumption of tobacco is not the only cause of this 
malignant tumor. Other factors are associated, affecting the incidence of this disease: 
exposure to arsenic, chromium, nickel and asbestos, cicatricial lesions of tuberculosis, and 
familiar history of lung cancer (Beckett WS, 1993) and (Figueiredo L et al., 1999). 
Studies in molecular biology have elucidated the role that genetic factors play in modifying 
an individual's risk for lung cancer. Although chemopreventive agents may be developed to 
prevent lung cancer, prevention of smoking initiation and promotion of smoking cessation 
are currently the best weapons to fight lung cancer (Bilello Ks et al., 2002). 
This malignant pathology, like most other solid tumors, is usually recognized late in its 
natural history. The five-year mortality from the time of presentation remains at 
approximately 85 to 90% and more than 90% of the patients with lung cancer will be 
symptomatic at presentation (Beckles MA et al., 2003). 
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Most patients with lung cancer present to the clinician in a fairly advanced stage and at best 
only 25-30% of patients can be offered curative resection (Kamath AV et al., 2006). A 
minority present with symptoms related to the primary tumor, and most patients present 
with either nonspecific systemic symptoms, including anorexia, weight loss and fatigue, or 
specific symptoms indicating metastatic disease (Beckles MA et al., 2003). 
One of the causes of the low survival rate from lung cancer is related to difficulty of its 
precocious diagnosis due to the absence of symptoms and to the poor diagnosis at more 
advanced stages of the disease (Jamnik S et al., 2002). Prognosis is related to the type of 
presenting symptoms (Beckles MA et al., 2003). 
Patients with lung cancer have a five-year survival rate varying from 13% to 21% in 
developed countries and varying from 7% to 10% in emerging countries (Silva AC et al., 
2011). 
However, when lung cancer is found at the early stage I or II, five-year survival rates can be 
as high as 60-70% (Beadsmoore CJ & Screaton NJ, 2003). The best survival rates are found in 
the subgroup of patients with lung cancer with surgically resectable tumors. Clinicians, 
therefore, are vitally interested in recognizing lung cancer early and determining surgical 
resectability accurately (Colice Gl, 1994). 
Symptoms, signs and abnormalities in laboratory tests relating to the lung cancer can be 
classified as follows: those related to the primary lesion, those related to intrathoracic 
spread, those related to distant metastasis, and those related to paraneoplastic syndromes 
(Beckles MA et al., 2003). 
Lung cancer is routinely classified as Small Cell Lung Cancer (SCLC) or Non Small Cell 
Lung Cancer (NSCLC) on the basis of distinctive pathological and molecular features but 
also for appropriate therapeutic management (Scagliotti GV et al., 2009). The distinction 
between SCLC and NSCLC came into proeminence when it was realized that SCLC was 
characterized by widespread metastatic spread at diagnosis and often displayed partial or 
complete response to conventional cytotoxic therapies (Gazdar AF, 2010). 
The NSCLC category encompasses several subtypes having different morphological features 
generally treated according to similar strategies, so that a clear cut distinction among these 
types was not considered mandatory and accounts for 80% to 85% of lung carcinoma and 
determining the prognosis for an individual patient with NSCLC is difficult, in part because 
of the marked clinical heterogeneity of patients with the disease. Patients with early stage 
NSCLC have relatively high long-term survival rates after surgical resection, but a 
substantial majority of patients, approximately 80%, present in advanced stages (Scagliotti 
GV et al., 2009) and (Wang T et al., 2010). 
SCLC is associated with poor diagnosis, with an average two-year survival rate of less than 
10%. Patients are usually symptomatic at diagnosis, 30% to 40% report dyspnea and chest 
pain. Only 4% to 5% of SCLC cases are detected as solitary pulmonary nodule. Therefore, 
SCLC differs markedly from NSCLC in biologic behavior and clinical behavior. SCLC it is 
associated with rapid growth, and almost two-thirds of patients have metastatic disease at 
presentation. The response to the initial phase of the treatment is usually good, with almost 
80% of the patients showing a major response (Argiris A & Murren JR, 2001) and (Oliveira C 
& Saraiva A, 2010). 
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The main histological types of this malignant disease include: adenocarcinoma, squamous 
cell carcinoma, SCLC and large-cell carcinoma. Adenocarcinoma accounts for 25 to 30% of 
NSCLC and is the most common histological type. It is typically classified as acinar, 
papillary, solid, and bronchioloalveolar varieties (Beckles MA et al., 2003) and (Patz EF Jr, 
2000). The incidence of adenocarcinoma has increased in recent decades, while the incidence 
of squamous cell carcinoma has reached a plateau or has decreased (Chen YM et al., 2009). 
A variety of techniques are available as methods of achieving a definitive diagnosis. The 
diagnostic evaluation of this disease has two main objectives: the definition of the 
pathological type of the tumor and staging of the disease (Westeel V, 2003). A diagnosis 
should be obtained by whatever method is easiest in patients who are presumed to have 
SCLC or who have very clear evidence of advanced NSCLC (e.g., a large pleural effusion or 
metastatic disease). The most appropriate test is usually determined by the type of lung 
cancer (SCLC or NSCLC), the size and location of the tumor, and the presumed stage of the 
cancer (Brundage MD et al., 2002). 
The available tools for diagnosing and staging lung cancer patients can be broadly 
categorized into non-invasive, minimally invasive and invasive (surgical) modalities (Hicks 
RJ et al., 2007). 
Current imaging for lung cancer makes use of chest radiographs, Computed Tomography 
(CT), Magnetic Resonance Imaging (MRI), and nuclear medicine. Most studies are designed 
to detect anatomic abnormalities, leading to some problems in sensitivity and especially 
specificity. In the future, imaging may be directed more at tumor biology, and perhaps then 
will have a greater impact on this devastating disease (Patz EF Jr, 2000). 
Although histology diagnosis is the most accurate detection method in the medical 
environment, it is an aggressive invasive procedure that involves risks, discomfort and 
trauma, which restrict it to be used in the clinical practice (Xiuhua G et al., 2011). 
A person who is at high-risk for lung cancer and asymptomatic, and who is interested in 
potentially being screened should be fully apprised of the implications of screening and of 
the treatment that may result. It is fulcral to mention that the value of screening for early 
disease is not yet established and trials to see if mortality can be improved as a result are in 
progress (Henschke CI et al., 2007) and (Spiro SG et al., 2010). 
It is important to refer that most symptomatic lung cancer is discovered at advanced stages, 
with the goal of long-term survival entirely dependent on effective treatment of stage III and 
IV lung cancer (Wang T et al., 2010). 
More accurate staging at the time of initial presentation could improve design of clinical 
trials and avoid inappropriate surgical decisions in individual patients (Roberts JR et al., 
1999). The TNM classification system for the staging of lung cancer has led to important 
advances in the determination of prognosis and treatment of patients with this disease 
(McLoud TC, 2006). TNM-staging has important influence on prognosis and therapy (Serke 
M & Schönfeld N, 2007). 
This system takes into account the degree of spread of the primary tumor (represented by 
T); the extent of regional lymph node involvement (represented by N); and the presence or 
absence of distant metastases (represented by M). The TNM system is used for all lung 
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carcinomas except SCLCs, which are staged separately. SCLC is staged as limited or 
extensive disease. Limited disease is localized enough to be included in a radiation port, 
while extensive disease includes distant metastases. 
Staging of extrathoracic disease is very important in providing optimal care for the patient 
with lung cancer (Shaffer K, 1997). The majority of the patients will have locally advanced or 
metastatic disease at the time of diagnosis (Stinchcombe TE et al., 2009). 
It is fulcral to mention that survival is inversely proportional to the stage, with early detection 
and diagnosis being the key to achieving surgical cure (Hollings N & Shaw P, 2002). 
An early diagnosis is the determining factor in the therapeutic selection. Surgery, 
Chemotherapy and Radiotherapy are the most frequently utilized types of treatment. It is 
important to refer that in SCLC surgery has a restricted use in management of this type of 
lung cancer, as only a few patients with limited disease may be eligible; chemotherapy is the 
primary form of treatment for both stages, and radiation is included for patients staged with 
limited disease (Argiris A & Murren JR, 2001). 
Surgery has a pivotal role in the treatment of bronchogenic carcinoma. Indeed, resection is 
the standard treatment of early stages (I and II) non-small cell lung cancer, remains optional 
for a portion of patients with a locally advanced disease (IIIA and IIIB) and in anecdotal 
carefully selected patients with an oligometastatic disease (IV) (Thomas PA, 2009). In many 
situations a combination of two or even three treatment modalities is necessary. 
In this chapter the authors will emphasize the role of Bronchoscopy and Computed 
Tomography in the diagnosis of Lung Cancer. 
2. Bronchoscopy 
Bronchoscopy is an essential tool in respiratory medicine, which allows visualization and 
sampling from the main airways and it is a central technique in diagnosing lung cancer, but 
also in different therapeutic approaches (Herth FJ et al., 2006). 
This exam is currently the most commonly employed invasive procedure in the practice of 
pulmonary medicine. Both the rigid and flexible bronchoscopes are used to diagnose and to 
treat various pulmonary disorders (Udaya B & Prakash S, 1999). 
It is important to emphasize that the most common indication for bronchoscopy is for tissue 
sampling and determining the extent of lung cancer and it is, also, utilized extensively in the 
initial evaluation of patients suspected of having this pulmonary malignant pathology 
(Simon M et al., 2010) and (Aristizabal JF et al., 1998). The indications for the bronchoscopic 
exam are extensive. The main diagnostic indications include pulmonary involvement by 
neoplasms, infections, diffuse lung diseases, and airway problems (Table 1) (Plekker D et al., 
2010), (Shah PL, 2008) and (Udaya B & Prakash S, 1999). 
The principal advantages of flexible bronchoscopy include a more extensive view of the 
tracheobronchial tree, case of performance, and no requirement for general anesthesia 
(Suleman A et al., 2008). 
Advancements in computer technology and engineering have allowed for the emergence of 
newer modalities to evaluate endobronchial, parenchymal, and mediastinal pathology (El- 
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Indications for Bronchoscopy 
Diagnostic 
Investigation of symptoms – Haemoptysis, Persistent cough, Recurrent Infection 
Investigation of abnormal chest imaging - Lung masses, Diffuse infiltrates, Atelectasis or 
Pleural effusions 
Diagnostic sampling of pathological processes - Endobronchial forceps biopsy, 
Transbronchial lung biopsy, Endobronchial brush, Bronchoalveolar lavage, Transbronchial 
needle aspiration 
Staging of lung cancer - Mediastinal tissue diagnosis and staging 
Infection - Identification of organisms (e.g. suspected tuberculosis), Evaluate airways if 
recurrent or persistent infection 
Interstitial Lung Disease – Bronchoalveloar lavage for differential cell count and histology 
Therapeutic
Foreign body removal, Management of massive haemoptysis, Endobronchial laser ablation, 
Electrocautery, Cryotherapy, Brachytherapy, Photodynamic therapy, Dilation of airway, 
Stent placement, Bronchoscopic lung volume reduction, Thermoplasty, Radiofrequency 
ablation 
Research
Endobronchial biopsies in research of airway diseases, Bronchoalveolar lavage in research 
of diffuse lung diseases 
Table 1. Indications for Bronchoscopy 
Bayoumi E et al., 2008). Bronchoscopy has an important role in the evaluation of suspected 
lung cancer, interstitial lung disease, persistent infection and the assessment of new 
pulmonary infiltrates in immunocompromised patients. Recent developments have ranged 
from the improvement in image quality to integration of ultrasound (Shah PL, 2008). 
Laser therapy, electrocautery, cryotherapy and stenting are well-described techniques for 
the palliation of symptoms due to airway involvement in patients with advanced stages 
(Simon M et al., 2010). 
The decision about whether to perform a diagnostic bronchoscopy for a lesion that is 
suspicious for lung cancer depends largely on the location of the lesion (central Vs 
peripheral) (Rivera MP et al., 2003). 
The bronchoscopic procedure requires specific training and experience in both flexible and 
rigid bronchoscopy. The recent advances in minimally invasive procedures has ultimately 
included a new array of therapeutic bronchoscopy for diseases which would otherwise not 
be treated, or offered only surgery, ended up adding a new variety of procedures that 
demand constant updates for the specialist to keep up with this rapidly evolving technology 
(Herth FJ et al., 2006). 
Various diagnostic accessories can be inserted through the working channel of the flexible 
bronchoscope. These accessories include biopsy forceps, needles, and brushes, and they 
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have greatly aided in the diagnosis and staging of lung cancers. Their combined effect has 
greatly improved the ability to obtain pulmonary biopsies, especially of ever smaller lesions 
(Herth FJ et al., 2006) and (Udaya B & Prakash S, 1999). 
Bronchoscopy with Transbronchial Needle Aspiration (TBNA) for cytologic or histologic 
examination of mediastinal lymph node has been shown to be a safe procedure (Rivera MP 
et al., 2003). 
Flexible bronchoscopy is an extremely safe procedure provided some basic precautions are 
taken. A recent retrospective analysis of 23.682 patients over a period of 11 years showed a 
mortality rate of 0.013% with a complication rate of 0.739% (Jin F et al., 2008). 
Complications may result from topical anesthesia, agents used for sedation or the procedure 
itself. Potentially life-threatening complications include respiratory depression, airway 
obstruction, arrhythmias, haemorrhage, infection and pneumothorax. Patient preparation 
for elective bronchoscopy includes fasting prior to procedure, informed consent, careful 
sedation in some cases, and topical anesthesia. Some of the contraindications include totally 
uncooperative patients, hemodynamically unstable patients, any severe acute illness and 
those who refuse to undergo the procedure (Plekker D et al., 2010) and (Suleman A et al., 
2008). 
Diagnostic yield depends on the location, size, character of the border of the lesion, and the 
ability to perform all sampling methods (Chechani V, 1996). The success rate of 
bronchoscopy in obtaining diagnostic pathologic material is significantly higher when a 
third- to fifth-order bronchus can be traced to the pulmonary nodule on a chest CT (positive 
CT bronchus sign) (Aristizabal JF et al., 1998). 
The role of flexible bronchoscopy in lung cancer includes the following: inspection of 
airways to detect ipsilateral and contralateral endobronchial disease and their biopsy; 
transbronchial biopsy of the pulmonary nodule or mass; detection of mediastinal and/or 
hilar adenopathy; and possible transbronchial needle aspiration of the hilar or mediastinal 
nodes (Aristizabal JF et al., 1998). Bronchoscopy is also important in staging and it is 
required a careful inspection of the upper airways, superior vocal cords, trachea, carina and 
bronchi. 
The endoscopic signs of lung carcinoma are variable, extending from a simple loss of 
brightness in a small area of the bronchial mucosa to a typical vegetative mass. Classically, 
three types of typical lesions or direct signs of tumor are taken into consideration: mass, 
infiltration and obstruction. However many other endoscopic changes or indirect signs 
(edema or local vascular fragility, localized inflammation or congestion, stenosis, bronchial 
stiffness and extrinsic compression) may correspond to a lung cancer so that, especially in 
patients at risk, these lesions should be investigated by aspiration and/or brushing and/or 
biopsy (Baughman RP et al., 1999) and (Cook RM et al., 1995). 
Central lesions can present as an exophitic endobronchial mass, submucosal spread or a 
peribronchial tumor causing extrinsic compression. Most studies defined peripheral lesion 
as lesions that are not visible in the main or lobar airways (Rivera MP et al., 2003). 
In central tumors endoscopically visible, studies referred a diagnostic yield of 91% to 94% in 
central lesions and 83% in peripheral lesions (Shure D, 1996). 
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The sensitivity of bronchoscopy for peripheral lesions is most affected by the size of the 
lesion. The False-Negative rate can be estimated to be fairly high in the case of peripheral 
lesions, especially smaller ones, because of the relatively low sensitivity in this setting 
(Rivera MP et al., 2003). 
A negative initial bronchoscopy in a suspected lung cancer patient implies a greater 
potential for excessive delays in diagnosis and treatment in spite of a greater chance of 
curative treatment. Most of the delay occurs in the interval from the outpatient appointment 
to decision-to-treat. Patients with negative bronchoscopy require a more concerted effort to 
achieve a timely diagnosis and treatment (Devbhandari MP et al., 2008). 
Bronchoscopy has, also, an important role in the diagnosis of benign conditions, but the 
chance of finding a benign condition in a patient who is clinically suspected of having lung 
cancer is only 1% (Rolston KVI et al., 1997). 
The role of both old and new diagnostic bronchoscopy will continue to evolve as further 
improvements are made in bronchoscopes, accessory equipment, and imaging technologies 
(Herth FJ et al., 2010).  
It is important to refer that special emphasis has been placed on their role in the early 
detection and staging of lung cancer. Some technology requires further study to delineate its 
role in the disease, whereas other modalities are emerging as the new gold standard in 
evaluation of lung cancer (El-Bayoumi E et al., 2008). 
3. Computed tomography 
Radiological studies play a fundamental role in every aspect of clinical medicine. Imaging 
offers invaluable information in establishing a diagnosis, guiding interventional procedures 
and directing patient management. Thus, imaging techniques play a crucial role in the 
diagnosis, staging and follow-up of patients with lung cancer. (Hansell DM et al., 2010) and 
(Wynants J et al., 2007). 
Computer aided diagnosis of lung CT image has been a remarkable and revolutionary step, 
in the early and premature detection of lung abnormalities. CT was introduced into clinical 
practice in the 1970s as an exciting new method for imaging the thorax. Since then, clinicians 
have come to rely heavily on CT for evaluating potentially malignant chest lesions and the 
intrathoracic spread of lung cancer (Colice GL, 1994). 
CT scanners can image the entire central airways in only half a second, allowing for 
dynamic cine imaging of the trachea and bronchi during respiratory manoeuvres (Hansell 
DM et al., 2010). 
High Resolution CT techniques developed in the last decade have become invaluable tools 
for the detection of subtle diffuse lung disease patterns and for their characterization into 
multiple possible diseases and they provide detailed information regarding the lung 
parenchyma and can delineate structures down to the level of the secondary pulmonary 
lobule. It is particularly useful for image-based diagnosis, since alteration of the lung 
anatomy, caused by a disease, can be clearly seen in a thin-slice CT image (Tatjana Z & 
Busayarat S, 2011). 
CT is still the basis of imaging studies in the preoperative staging and post- therapeutic 
evaluation of lung cancer and is currently the best imaging modality for diagnosing lung 
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diseases. The most recent developments in multidetector technology have dramatically 
improved the temporal and spatial resolution of CT (Lauren F et al., 2006) and (Tatjana Z & 
Busayarat S, 2011). 
A chest CT is obtained in most of the patients with a pulmonary nodule or mass. A large 
body of imaging literature suggests that CT is a sensitive method to evaluate the proximal 
bronchi for neoplasm. It is also suggested that CT is helpful in predicting the yield of 
bronchoscopy in obtaining pathologic diagnosis of a pulmonary nodule or mass. In addition 
to demonstrating the location of the nodule (lobe, peripheral vs. central location), CT can 
also demonstrate if a third or fourth-order bronchus leads to or is contained within the 
pulmonary nodule or mass (Aristizabal JF et al., 1998). 
CT plays a relevant role in the determination of presence and extent of lung cancer, 
demonstrating the size and site of the tumor. However, this exam presents some 
limitations such as high cost, utilization of ionizing radiation, contrast agent 
nephrotoxicity, besides the necessity of further procedures to confirm the diagnosis 
(Oliveira C & Saraiva A., 2010). 
The findings of CT scans of the chest and clinical presentation usually allow a presumptive 
differentiation between SCLC and NSCLC. CT may also predict the yield of bronchoscopy 
in making a tissue diagnosis of pulmonary nodule or mass, if the predictive value of 
bronchoscopy is low, an alternate method of diagnosis may be chosen. CT can identify 
specific features in lung nodules that are diagnostic (e.g. arteriovenous fistulae, rounded 
atelectasis, fungus balls, mucoid impaction and infarcts) (Aristizabal JF et al., 1998), 
(Hollings N & Shaw P, 2002) and (Rivera MP et al., 2003). 
This imaging modality also assists the implementation of complementary techniques 
including transthoracic needle aspiration biopsy, mediastinoscopy or video-assisted thoracic 
surgery (Landreneau RJ et al., 1996). 
The CT indispensability in the study of lung cancer is associated with the obligatoriness of 
endoscopy of the respiratory tract with flexible endoscope (Cordeiro AJA Robalo, 1995). 
Computed Tomography can detect tumors as small as 0.5 cm compared to a chest 
radiography which detects tumors at 3 cm. Yet, it is important to note that smaller tumor 
size does not necessarily equate to an early stage cancer as each tumor has its own growth 
pattern and disease development (Read et al., 2006). 
It is important to note that pulmonary nodules of lung cancer in CT images share similarity 
with benign cases to some extent (such as tuberculosis, inflammatory pseudotumor, 
hamartoma, and aspergillosis) which makes it difficult to distinguish (Jee WC et al., 2008). 
The majority of patients who present with lung cancer undergo CT scanning of the chest 
and liver (adrenal glands should be routinely included if lung cancer is suspected) and it is 
useful in helping to distinguish vascular structures from lymph nodes as well as in 
delineating mediastinal invasion by centrally located tumors (Al Jahdali H, 2008). Prediction 
of lymph node metastasis using combination of gene signatures and chest CT is superior to 
the CT-only diagnosis (Chang JW et al., 2008). 
Morphologic imaging techniques such as CT cannot always differentiate reliably between 
benign and malignant lesions, as enlarged nodes may also be inflammatory whereas 
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normal-sized lymph nodes may contain malignancy. Thoracic CT is the most commonly 
used noninvasive staging method of the mediastinum (Harewood GC et al., 2002). CT 
scanning reliably depicts mediastinal invasion, provided that the tumor surrounds the 
major mediastinal vessels or bronchi. So it is fulcral to mention that CT of the chest is an 
important imaging modality that helps in detailed imaging of the primary tumor and its 
anatomic relationship to other structures, and it provides information with respect to the 
size of mediastinal lymph nodes and the status of the pleural space. 
Currently available results on CT screening for lung cancer show that the work-up on 
baseline screening can be confined to less than 15% of the individuals and to less than 6% on 
annual repeat screening, almost all cases are detected by screening with very few diagnoses 
made between screening on the prompting of symptoms, and over 80% of all the diagnoses 
are of Stage I (Henschke CI et al., 2005). 
Although the introduction of low-dose spiral CT is considered to be one of the most 
promising clinical research developments, CT screening is used for detecting small 
peripheral lesions. CT screening is a far more sensitive method than conventional 
radiography for identifying small, potentially early-stage, lung cancers (Hansell DM et al., 
2010) and (Yasufuku K, 2010). 
CT scanning of the chest is useful in providing anatomic detail that better identifies the 
location of the tumor, its proximity to local structures, and whether or not lymph nodes in 
the mediastinum are enlarged (Silvestri GA et al., 2007). CT enables us to see the lung 
anatomy in great detail and has been used to accurately diagnose lung diseases and is a 
remarkable technique for visualizing structures within the thorax (Colice GL, 1994) and (Xu 
Y et al., 2006). 
In the decades, CT has been the main diagnosis tool of lung cancer for its convenience and 
safety, and widely used in clinical practice. However, it is difficult to distinguish between 
benign and malignant cases in the CT images of pulmonary nodules, especially for the 
doctors who were lack of experience. This imaging modality is useful in predicting the 
likelihood of achieving positive histocytology at Flexible Bronchoscopy. The overall CT 
prediction is superior to any of the individual CT features taken alone (Bungay HK et al., 
2000) and (Xiuhua G et al., 2011). 
4. CT Vs bronchoscopy in the diagnosis of lung cancer 
4.1 Purpose 
The main objective of this study was to analyze the role of Bronchoscopy and CT in the 
diagnosis of lung cancer by evaluating the effectiveness of these techniques in the presence 
of this malignant pathology. 
It is important to emphasize that the possibility to evaluate two important diagnostic 
methods in the presence of Lung Cancer is the main factor that justifies this study. 
4.2 Methods 
This retrospective study was conducted with the approval of the institutional review board 
of the Hospital Distrital da Figueira da Foz. 
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This investigation was done in the Department of Pneumology of the Hospital Distrital da 
Figueira da Foz, between January and July 2009. 
To carry out this study, the medical records of 70 patients were analyzed (42 patients were 
men and 28 patients were women; the mean age was 66 years). 
These patients were referred to the Department of Pneumology of the Hospital Distrital da 
Figueira da Foz (along a four-year period - January 2003 to January 2007) and submitted to 
Bronchoscopy and Computed Tomography for suspicion of Lung Cancer, confirmed or not 
by the study of the pathology. 
It is fulcral to refer that bronchoscopy and CT exams were considered as either negative or 
positive according to the information included in the respective reports. Bronchoscopy 
exams and the subsequent reports were performed by a Pneumologist. A Radiologist 
performed the chest CT exams and prepared the respective reports. 
In this investigation agreements between the results of the exam and the presence or 
absence of lung cancer were analyzed by calculating Cohen Kappa statistics. Agreements 
were assessed for both exams in study (Bronchoscopy and Computed Tomography). 
4.3 Results and discussion 
It is important to mention that among the 70 patients submitted to bronchoscopy and CT, 37 
were diagnosed with lung cancer. 
The statistical analysis permitted to observe that the relation between the bronchoscopy 
results and the presence or absence of lung cancer was statistically significant (p < 0.05). 
Also the Kappa Value 0.656 demonstrated a good rate of agreement between the results. 
It is primordial to refer that the authors observed that in the 37 positive bronchoscopic 
studies, 83.8% corresponded to the presence of cancer, and 16.2% to a negative diagnosis 
of this lung pathology. As regards the 33 negative bronchoscopic exams, 81.8% 
corresponded to the absence of lung cancer, and 18.2% to the presence of this malignant 
pathology (Table 2). 
The relation between CT results and the presence or absence of lung cancer was considered 
statistically significant (p < 0.05), after the statistical analysis. The kappa value was 0.451, 
corresponding to a weak agreement between the results. 
Among the 42 CT studies interpreted as positive, 71.4% corresponded to the presence of this 
malignant pathology, and 28.6% corresponded to the absence of this pathology. In the 28 CT 
studies read as negative, 75% corresponded to a negative diagnosis of lung cancer, and 25% 
demonstrated the presence of this disease (Table 3). 
In Table 4 is possible to observe the sensitivity, specificity, accuracy, false-positive and false-
negative of bronchoscopy and CT scans. In this study, Bronchoscopy sensitivity was 83.8%, 
specificity 81.8%, and accuracy 82.8%. False-positive results corresponded to 18.2%, and 
false-negative results to 16.2%. 
The CT sensitivity was 81.1%, specificity 63.6%, and accuracy 72.8%. False-positive results 
corresponded to 36.4% and false-negative results to 18.9%. 
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Presence or Absence of Lung Cancer 
TOTAL 
PRESENT ABSENT 
Bronchoscopy 
POSITIVE 
N 31 6 37 
% Bronchoscopy 83.8% 16.2% 100.0% 
% Total 44.3% 8,6% 52.9% 
NEGATIVE 
N 6 27 33 
% Bronchoscopy 18.2% 81.8% 100.0% 
 % Total 8.6% 38.6% 47.1% 
TOTAL 
N 37 33 70 
% Bronchoscopy 52.9% 47.1% 100.0% 
% Total 52.9% 47.1% 100.0% 
Table 2. Relation between the results of Bronchoscopy and the Presence or Absence of Lung 
Cancer (2 = 30.125; gl = 1; p = 0; Kappa value = 0.656) 
 
 
Presence or Absence of Lung Cancer 
TOTAL 
PRESENT ABSENT 
CT 
POSITIVE 
N 30 12 42 
% CT 71.4% 28.6% 100.0% 
% TOTAL 42.9% 17.1% 60.0% 
NEGATIVE 
N 7 21 28 
% CT 25.0% 75.0% 100.0% 
% TOTAL 10.0% 30.0% 40.0% 
TOTAL 
N 37 33 70 
% CT 52.9% 47.1% 100.0% 
% TOTAL 52.9% 47.1% 100.0% 
Table 3. Relation between the results of CT exams and the Presence or Absence of Lung 
Cancer (2 = 14,533; gl=1; p=0; Kappa value =0,451) 
 
 SENSITIVITY SPECIFICITY ACCURACY
FALSE-
POSITIVE 
FALSE-
NEGATIVE 
Bronchoscopy 83.8% 81.8% 82.8% 18.2% 16.2% 
CT 81.1% 63.6% 72.8% 36.4% 18.9% 
Table 4. Sensitivity, Specificity, Accuracy, False-Positive and False-Negative of 
Bronchoscopy and CT Exams 
The results of Bronchoscopy confirmed the fact that this is an important test in the diagnosis 
of lung cancer, by its diagnostical dependence in the pathological examination of tissue or 
cells obtained by various techniques of biopsy. Several studies have demonstrated that more 
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than 70% of lung carcinomas are visible to bronchoscopy and combining bronchial biopsy, 
bronchial brushing, and bronchial washing results in an excellent diagnostic yield (Govert 
JA et al., 1998) and (Herth FJF, 2011). 
The false-negative results of bronchoscopy found in the current study (16.2%) are due to the 
presence of peripheral lesions, particularly the smaller ones, because of the poor role played 
by bronchoscopy in these cases. Some published studies indicate that the sensitivity of 
bronchoscopy is poor for peripheral lesions that are < 2 cm in diameter (Chechani V, 1996), 
(Popovich J Jr et al., 1982) and (Schreiber G et al., 2003). 
In the present investigation the authors obtained a sensitivity of 81.1% for CT, corroborating 
reports in the literature demonstrating that as lung cancer is detected by radiological 
methods, ¾ of the natural history of the pathology were already completed (Scagliotti G, 
2001). 
Radiology has traditionally played a crucial role in the evaluation and follow-up of patients 
with lung cancer. That role has changed with time, particularly with advances in surgical 
treatment and the introduction of new, less invasive techniques, such as video-assisted 
thoracoscopy and different imaging modalities have been used in the diagnosis and staging 
of lung cancer; reports refer that CT plays an important role in the diagnosis of lung cancer, 
however has been limited by uncertain detection rate for early stage of NSCLC, particularly 
central tumors (Jiang F et al., 2009) and (Shaffer K, 1997). CT scanning is required for a better 
delineation of the abnormality detected on plain radiographs. 
Some studies in the literature mention that imaging plays an essential role in diagnosing, 
staging, and following patients with lung cancer (Patz EF Jr, 1999) and (Sarinas PS et al., 
1996). 
The specificity of CT in this investigation is a result of the number of false-positive results 
(36.4%) and this situation is due to the fact that radiological findings suggestive of lung 
cancer (that lead to the rate of a CT study as positive) such as parenchymal mass with 
speculated margins, thickwalled cavities, microlobulations, cavitary nodules and chest wall 
invasion may be observed in other diseases such as infections, pulmonary inflammatory 
processes, infarction and lung abscesses (George CJ et al., 2004), (Madhusudhan KS et al., 
2007) and (Runciman DM et al., 1993). 
Several studies indicate that the high proportion of false-positive CT findings may reach 
70% and thus, histological confirmation is essential for diagnosis (Makris D et al., 2007) and 
(Swensen SJ et al., 2005). 
5. Conclusion 
Lung cancer is a common pathology that has a poor prognosis and survival is inversely 
proportional to the stage, with early detection and diagnosis being the key to achieving 
surgical cure. 
Despite medical advances lung cancer remains the leading cause of cancer deaths (Serke M 
& Schönfeld N, 2007). 
The diagnosis of lung cancer is essentially achieved by CT and bronchoscopic techniques. 
During these years numerous improvements of these diagnostic tools have been made 
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available, which aspire to reduce the time to diagnosis and to simplify the initial staging 
approach. 
The modality selected to diagnose a suspected lung cancer is based on the size and location 
of the primary tumor in the lung, the presence of potential metastatic spread, and the 
anticipated treatment plan (Schreiber G et al., 2003). 
The main goals in selecting a specific diagnostic modality are to maximize the yield of the 
selected procedure for both diagnosis and staging and to avoid unnecessary invasive tests. 
The selection of the most appropriate test is done in a multidisciplinary way with 
contribution from a pulmonologist, radiologist and thoracic surgeon (Rivera MP et al., 2003). 
The radiological diagnosis has become a key element in the evaluation and management of 
the patients with lung cancer and, in some instances, accurate staging and determination of 
appropriate treatment can be done noninvasively, with only imaging modalities, although 
in numerous situations surgical staging is also necessary. 
Flexible Bronchoscopy with its attendant procedures is a valuable diagnostic tool in the 
workup of a patient who is suspected of having lung cancer. In the last decade, major 
advances have been made in interventional bronchoscopy. 
Bronchoscopy results in this study corroborated the relevance of this method in the 
diagnosis of this malignant pathology, considering its dependence on the 
anatomopathological study of tissue or cells obtained through different biopsy techniques. 
CT is today one of the cornerstones of imaging techniques and with the improved technical 
quality of CT scans, more small lesions are now detectable in the lungs. 
The specificity of CT is limited and a histologic diagnosis or follow-up evaluation is, usually, 
necessary. The potential benefits of introducing CT screening for lung cancer detection may 
be its ability to detect more early stage tumors and decrease the numbers of later stage 
disease. And CT can best be thought of as a imaging tool that can provide a roadmap for 
more accurate surgical staging. 
It is important to emphasize that in the detection and diagnosis of lung cancer should be 
carried out complementary exams that include CT and Bronchoscopy. 
6. Definitions 
False positive - is the proportion of absent events that yield positive test outcomes, i.e., the 
conditional probability of a positive test result given an absent event. 
False – Negative – is the proportion of events that are being tested for which yield negative 
test outcomes with the test, i.e., the conditional probability of a negative test result given 
that the event being looked for has taken place. 
Sensitivity - measures the proportion of actual positives which are correctly identified as 
such (e.g. the percentage of sick people who are correctly identified as having the 
condition). 
Specificity - measures the proportion of negatives which are correctly identified (e.g. the 
percentage of healthy people who are correctly identified as not having the condition).  
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Positive predictive value - is the proportion of subjects with positive test results who are 
correctly diagnosed. It is a critical measure of the performance of a diagnostic method, as it 
reflects the probability that a positive test reflects the underlying condition being tested for.  
Negative predictive value - is a summary statistic used to describe the performance of a 
diagnostic testing procedure. It is defined as the proportion of subjects with a negative test 
result who are correctly diagnosed. A high NPV means that when the test yields a negative 
result, it is uncommon that the result should have been positive 
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